Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD.
Chen X, Zheng X, Lu N, Zhang R, Zhai W, Ma Q, Pang A, Yang D, Wei J, He Y, Feng S, Han M, Jiang E.
Chen X, et al.
Int Immunopharmacol. 2023 Dec;125(Pt A):111165. doi: 10.1016/j.intimp.2023.111165. Epub 2023 Nov 5.
Int Immunopharmacol. 2023.
PMID: 37935091
Free article.
Review.